Changes

Jump to: navigation, search

Alopecia - Hair Loss

8 bytes removed, 11:57, 28 April 2006
!width="300" bgcolor=DodgerBlue|'''Composition'''
!width="300" bgcolor=DodgerBlue|'''Composition action'''
|- style="height:100px40px"
|bgcolor=Plum|US20060009430
BLOTECH (2004)
Beta-sitosterol reduce inflammation on scalp
|- style="height:100px40px"
|bgcolor=Plum|US20060009427
WARNER LAMBERT(2004)[http://appft1.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PG01&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.html&r=1&f=G&l=50&s1=%2220060009427%22.PGNR.&OS=DN/20060009427&RS=DN/20060009427]
|bgcolor=Plum|New class of 4-cycloalkoxy benzonitrile derivatives and salts
|bgcolor=Plum|Acts as androgen receptor modulators and blocks formation of DHT.
|- style="height:100px40px"
|bgcolor=Plum|US20050085467
WARNER LAMBERT(2004)
|bgcolor=Plum|New class of 6-sulfonamido-quinolin-2-one and 6-sulfonamido-2-oxo-chromene derivatives.
|bgcolor=Plum|The compounds inhibit, or decrease, activation of androgen receptor by androgens.
|- style="height:100px40px"
|bgcolor=Plum|US20050118282
APHIOS Corp (2003)
|bgcolor=Plum|Supercritical fluid isolate of Saw Palmetto and Sperol (Serenoa repens berry) and their analogs or derivatives.
|bgcolor=Plum|Modulates androgenic activity by inhibiting 5.alpha.-reductase activity.
|- style="height:100px40px"
|bgcolor=Plum|US20060009429
Fundacion Pablo Cassara (2003)
|bgcolor=Plum|Pharmacologically active oligonucleotides (encompass both DNA and S-DNA bond)
|bgcolor=Plum|Oligonucleotides inhibit androgen receptor (AR) expression at very low concentrations in skin and hair follicle
|- style="height:100px40px"
|bgcolor=Plum|US20030007941
PFIZER INC (2001)
|bgcolor=Plum|Thyromimetic compounds (structurally similar to thyronine) with finasteride, or cyproterone acetate
|bgcolor=Plum|Activates thyroid hormone receptors in hair follicle which in turn promote elasticisation of follicle walls and hair follicle
|- style="height:100px40px"
|bgcolor=Plum|US20030073616
N/A (1995)
|bgcolor=Plum|Bradykinin antagonist (peptide of plasma origin from kininogen precursor-kallikrein)
|bgcolor=Plum|Inhibit synthesis of bradykinin receptors or compounds by binding to B2 receptor
|- style="height:100px40px"
|bgcolor=Plum|EP0279010
KAO Corp (1987)
0
edits